DMK Pharmaceuticals On Oct 11, Got Notice From Nasdaq Co's Common Stock Was Subject To Delisting Unless Co Timely Requests Hearing Before Panel
DMK Pharmicals于10月11日收到纳斯达克公司普通股的通知,除非公司及时要求在小组面前举行听证会,否则可能会退市
DMK Pharmaceuticals On Oct 11, Got Notice From Nasdaq Co's Common Stock Was Subject To Delisting Unless Co Timely Requests Hearing Before Panel
DMK Pharmicals于10月11日收到纳斯达克公司普通股的通知,除非公司及时要求在小组面前举行听证会,否则可能会退市
使用浏览器的分享功能,分享给你的好友吧